Advertisement

 

 

Risks and benefits HIV preexposure prophylaxis with tenofovir/emtricitabine in an older male with comorbidities.

Risks and benefits HIV preexposure prophylaxis with tenofovir/emtricitabine in an older male with comorbidities.
Author Information (click to view)

Girometti N, Jones R, Levy J, McCormack S, Sullivan A, Barber TJ,


Girometti N, Jones R, Levy J, McCormack S, Sullivan A, Barber TJ, (click to view)

Girometti N, Jones R, Levy J, McCormack S, Sullivan A, Barber TJ,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

AIDS (London, England) 30(13) 2131-3 doi 10.1097/QAD.0000000000001171

Abstract

Renal toxicity in a 73-year-old male, using tenofovir/emtricitabine as preexposure prophylaxis, is described. Reduced renal reserve, a higher exposure to comedications and comorbidities can present a challenge when assessing the risks and benefits of tenofovir-based preexposure prophylaxis in the ageing population.

Submit a Comment

Your email address will not be published. Required fields are marked *

2 × one =

[ HIDE/SHOW ]